China NMPA Product Recall - Push Button Blood Collection Set

The National Medical Products Administration (NMPA) announced on July 18, 2022, a voluntary Class II recall initiated by Becton Dickinson and Company. This action was reported by Becton Medical Devices (Shanghai) Co., Ltd., concerning specific models and batches of the company's Push Button Blood Collection Set (Registration Certificate No.: 20163222182). The primary issue identified leading to this recall involves product defects where users have reported damaged tubing or blood leakage from the tubing during the use of these medical devices. Such failures pose a potential risk to patient and healthcare worker safety by compromising the integrity of the blood collection process. Operating under the regulatory oversight of the NMPA, Becton Dickinson and Company proactively decided to recall the affected products. A Class II recall signifies that the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. The company is required to provide further details regarding the specific models, specifications, and batch numbers of the impacted Push Button Blood Collection Sets in a dedicated Medical Device Recall Event Report Form. This comprehensive reporting ensures that healthcare facilities and users can accurately identify and remove the faulty products from circulation, mitigating potential harm and ensuring compliance with medical device safety standards set by the NMPA.